Welcome to our dedicated page for ETRACS Whitney US Critical Techs ETN SEC filings (Ticker: WUCT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for WUCT aggregates regulatory documents tied to ETRACS Whitney US Critical Technologies ETNs issued by UBS AG, a foreign private issuer. The core filings here are Forms 6-K, which provide interim financial and legal updates that are incorporated by reference into UBS AG’s Form F-3 registration statement for securities offerings.
In these Form 6-K reports, UBS AG discloses consolidated capitalization in US dollars under IFRS Accounting Standards, detailing short-term and long-term debt issued by UBS AG and its subsidiaries, funding from UBS Group AG, equity attributable to shareholders and non-controlling interests, and total capitalization. Such information helps investors understand the broader balance sheet context of the issuer behind the WUCT-linked ETNs.
The filings also explain how specific 6-K reports are incorporated into UBS AG’s Form F-3 registration statement and any outstanding prospectuses or offering circulars that reference those 6-Ks. This structure means that updates filed on Form 6-K become part of the official documentation for securities, including the ETRACS Whitney US Critical Technologies ETNs associated with WUCT.
Another Form 6-K on this page consists of the opinion of Homburger AG, acting as special Swiss counsel to UBS AG, which is filed as an exhibit to the Form F-3 registration statement and replaces a prior opinion. This highlights the role of legal opinions in UBS AG’s securities registration process.
On Stock Titan, users can access these filings in one place, with AI-powered tools available to summarize key sections, highlight important capitalization and legal disclosures, and help interpret how each new Form 6-K or related document fits into UBS AG’s overall reporting framework for the WUCT-linked ETNs.
UBS AG has filed a preliminary pricing supplement for a new structured product: Trigger Autocallable Contingent Yield Notes linked to the American Depositary Receipts of Arm Holdings plc (ARM). The Notes are unsecured, unsubordinated debt of UBS AG, scheduled to price on June 20 2025, settle on June 24 2025 and mature on June 24 2026, unless called earlier. Investors will receive a contingent coupon of 14.07 %–16.07 % per annum only when the ADR’s closing level on an observation date is at or above the 60 % coupon barrier. Observation dates are monthly.
Automatic Call. If on any observation date prior to final valuation the ADR closes at or above its initial level, the Notes are automatically redeemed at par plus the contingent coupon, terminating further payments. Downside Protection. If not called, principal is protected only when the final ADR level is ≥ 60 % of the initial level (the downside threshold). Should the final level fall below that threshold, investors incur a loss equal to the full negative return of ARM ADRs and could lose their entire principal.
Key economics. Issue price is $10.00 per Note; underwriting discount is $0.125; proceeds to UBS are $9.875. UBS estimates the initial economic value at $9.54–$9.79, reflecting internal funding costs. Minimum investment is 100 Notes ($1,000). The product will not be listed on an exchange and secondary liquidity is expected to be limited. Payments depend entirely on UBS’s creditworthiness; the Notes are not FDIC-insured.
Risks highlighted. Investors face (i) credit risk of UBS, (ii) market risk equivalent to a 40 % downside buffer only at maturity, (iii) reinvestment risk if automatically called, (iv) potential illiquidity caused by the lack of listing and T+2 settlement versus the market’s T+1 norm, and (v) the possibility of receiving no coupons over the life of the security.